Connect with us

Hi, what are you looking for?

Economy

European trust in AstraZeneca COVID-19 vaccine plunges, poll shows

LONDON — Confidence in the safety of AstraZeneca’s coronavirus disease 2019 (COVID-19) vaccine has taken a big hit in Spain, Germany, France, and Italy as reports of rare blood clots have been linked to it and many countries briefly stopped using it, poll data showed on Monday.

The polling firm YouGov said it had already found in late February that Europeans were more hesitant about the AstraZeneca vaccine than about those from Pfizer Inc./BioNTech and Moderna, Inc. and that the clot concerns had further damaged public perceptions of the AstraZeneca shot’s safety.

At least 13 European countries in the past two weeks stopped administering the AstraZeneca shot, co-developed with scientists at Oxford University, after reports of a small number of blood disorders.

Many resumed its use on Friday after the European Medicines Agency (EMA) regulator said in a preliminary safety review on Thursday that the vaccine was safe and effective and not linked with a rise in the overall risk of blood clots.

EMA did not rule out a possible link, however, with rare cases of blood clots in the brain known as cerebral venous sinus thrombosis (CVST).

YouGov’s poll—which covered about 8,000 people in seven European countries between March 12 and 18—found that in France, Germany, Spain, and Italy, people were now more likely to see the AstraZeneca vaccine as unsafe than as safe.

Some 55% of Germans say it is unsafe, while less than a third think it is safe, the poll showed. In France, where AstraZeneca’s COVID vaccine was already unpopular, 61% of people polled say they now see it as unsafe.

In Italy and Spain, most people previously felt the AstraZeneca vaccine was safe—at 54% and 59% respectively—but those rates have fallen to 36% and 38% respectively, in the latest poll.

The survey showed that only in Britain, where the AstraZeneca COVID-19 vaccine has been used in a national rollout since January, have the blood clot concerns had little to no impact on public confidence. The majority of people polled in the UK—77%—still say the shot is safe. Their trust in it is on a par with Pfizer’s 79% perceived safety rating.

YouGov also said there appeared to be no spillover concerns across the seven European countries polled for the Pfizer and Moderna COVID-19 vaccines, both of which were seen as being as safe as in a poll three weeks ago. — Kate Kelland/Reuters

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest

Investing

The goal for most businesses is to grow, so the concept of bad growth may seem counterintuitive to a lot of business owners. However,...

Investing

Employees of all companies will be able to request flexible working arrangements when they start new jobs under proposals to be published by ministers....

Investing

Our perspectives on remote working have changed dramatically over the course of the pandemic. No doubt many employers in 2019 would have assumed that...

Economy

The Bangko Sentral ng Pilipinas (BSP) lowered the country’s balance of payments (BoP) surplus projection for this year, reflecting the lower current account surplus and the risks...

Economy

The Securities and Exchange Commission (SEC) is encouraging more companies to tap the capital markets, in hopes that there would be over 800 companies listed at...

Economy

Outsourcing firms operating in economic zones are allowed to implement remote work arrangements until March 2022 as the pandemic continues, the Finance department said...

You May Also Like

Investing

Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...

Economy

Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...

Investing

As a traditionally rigid insurance industry becomes bogged down by antiquated processes and operations, a handful of industry leaders are seeking to shake things...

Economy

US President Joseph R. Biden, Jr., will rely on ally countries to supply the bulk of the metals needed to build electric vehicles and focus on...

Disclaimer: SmartRetirementReport.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.



Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!